These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8270496)

  • 41. [Unusual amidation reaction of Asn-containing glycopeptide antibiotics using the coupling reagent PyBOP].
    Olsuf'eva EN; Solov'eva SE; Reznikova MI; Korolev AM; Preobrazhenskaia MN
    Bioorg Khim; 2013; 39(2):141-50. PubMed ID: 23964514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The structure of the aglycon of eremomycin--a new antibiotic of the polycyclic glycopeptide group].
    Berdnikova TF; Tokareva NL; Abramova EA; Dokshina NIu; Potapova NP
    Antibiot Khimioter; 1988 Aug; 33(8):566-70. PubMed ID: 2848466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci.
    Rodriguez MJ; Snyder NJ; Zweifel MJ; Wilkie SC; Stack DR; Cooper RD; Nicas TI; Mullen DL; Butler TF; Thompson RC
    J Antibiot (Tokyo); 1998 Jun; 51(6):560-9. PubMed ID: 9711219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-Terminus Alkylation of Vancomycin: Ligand Binding Affinity, Antimicrobial Activity, and Site-Specific Nature of Quaternary Trimethylammonium Salt Modification.
    Wu ZC; Isley NA; Boger DL
    ACS Infect Dis; 2018 Oct; 4(10):1468-1474. PubMed ID: 30067012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.
    Malabarba A; Ciabatti R; Scotti R; Goldstein BP; Ferrari P; Kurz M; Andreini BP; Denaro M
    J Antibiot (Tokyo); 1995 Aug; 48(8):869-83. PubMed ID: 7592033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships of vancomycin-type glycopeptide antibiotics.
    Nagarajan R
    J Antibiot (Tokyo); 1993 Aug; 46(8):1181-95. PubMed ID: 8407579
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.
    Balzarini J; Keyaerts E; Vijgen L; Egberink H; De Clercq E; Van Ranst M; Printsevskaya SS; Olsufyeva EN; Solovieva SE; Preobrazhenskaya MN
    Antiviral Res; 2006 Oct; 72(1):20-33. PubMed ID: 16675038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates.
    Shi W; Chen F; Zou X; Jiao S; Wang S; Hu Y; Lan L; Tang F; Huang W
    Bioorg Med Chem Lett; 2021 Aug; 45():128122. PubMed ID: 34015504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
    Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrid glycopeptide antibiotics.
    Sun B; Chen Z; Eggert US; Shaw SJ; LaTour JV; Kahne D
    J Am Chem Soc; 2001 Dec; 123(50):12722-3. PubMed ID: 11741455
    [No Abstract]   [Full Text] [Related]  

  • 52. Glycopeptide antibiotics: from conventional molecules to new derivatives.
    Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
    Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential scorpionate antibiotics: targeted hydrolysis of lipid II containing model membranes by vancomycin-TACzyme conjugates and modulation of their antibacterial activity by Zn-ions.
    Bauke Albada H; Arnusch CJ; Branderhorst HM; Verel AM; Janssen WT; Breukink E; de Kruijff B; Pieters RJ; Liskamp RM
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3721-4. PubMed ID: 19524434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity.
    Nadkarni SR; Patel MV; Chatterjee S; Vijayakumar EK; Desikan KR; Blumbach J; Ganguli BN; Limbert M
    J Antibiot (Tokyo); 1994 Mar; 47(3):334-41. PubMed ID: 8175486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic activities and affinities for bacterial cell wall analogue of N-demethylvancomycin and its derivatives.
    Yan H; Qi D; Cheng X; Song Z; Li W; He B
    J Antibiot (Tokyo); 1998 Aug; 51(8):750-6. PubMed ID: 9766467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structural biology of molecular recognition by vancomycin.
    Loll PJ; Axelsen PH
    Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antibiotic N',N''-dibenzyleremomycin with reduced 1,2-peptide bond].
    Printsevskaia SS; Olsuf'eva EN; Lazhko EI; Preobrazhenskaia MN
    Bioorg Khim; 2002; 28(1):72-80. PubMed ID: 11875978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibacterial activity of G6-quaternary ammonium derivatives of a lipophilic vancomycin analogue.
    Blizzard TA; Kim RM; Morgan JD; Chang J; Kohler J; Kilburn R; Chapman K; Hammond ML
    Bioorg Med Chem Lett; 2002 Mar; 12(6):849-52. PubMed ID: 11958977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin].
    Berdnikova TF; Lomakina NN; Olsuf'eva EN; Aleksandrova LG; Potapova NP; Rozynov BV; Malkova IV; Orlova GI
    Antibiot Khimioter; 1991 Jun; 36(6):28-31. PubMed ID: 1910324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and antibacterial activity of derivatives of the glycopeptide antibiotic A-40926 N-alkylated at the aminoglucuronyl moiety.
    Pavlov AY; Preobrazhenskaya MN; Malabarba A; Ciabatti R
    J Antibiot (Tokyo); 1998 May; 51(5):525-7. PubMed ID: 9666185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.